Cardiac Disease in Chronic Uremia: An Overview
Mortality among patients in the United States with end-stage renal disease (ESRD) approaches 20% to 21% per year . However, this aggregrate statistic masks considerable differences in the mortality rate, which shows substantial variation by patient age, race, gender, primary diagnosis causing renal failure, modality of treatment, and cause of death. In this chapter, we focus on the largest single cause of death, cardiovascular disease, which accounted for 50% of all ESRD deaths in 1988 .
KeywordsPeritoneal Dialysis Dialysis Patient ESRD Patient Cerebrovascular Accident Continuous Ambulatory Peritoneal Dialysis
Unable to display preview. Download preview PDF.
- 1.U.S. Renal Data System, USRDS. 1990. Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, August.Google Scholar
- 2.Cox D. 1972. Regression models and life tables. JR Stat Soc 34:187–201.Google Scholar
- 3.U.S. Department of Health and Human Services, Health Care Financing Administration. 1988. Medicare Statistical Files Manual. Baltimore, MD: HCFA Publication No. 03272.Google Scholar
- 4.Harrell F. 1980. The PHGLM procedure. In Reinhardt PS (ed), SAS Supplemental Library User’s Guide. Cary, NC: SAS Institute Inc, pp. 119–132.Google Scholar
- 6.Held PJ, Garcia JR, Blagg CR, Wolfe RA, Eggers PW, Port FK, FitzSimmons SC. 1990. Trends in mortality rates among dialysis and transplant patients in the U.S. Kidney Int 37:239.Google Scholar
- 8.Gentile DE. 1990. Geriatric Advisory Committee: Peritoneal dialysis in geriatric patients: A survey of clinical practices. Adv Pernt Dial 6 (suppl):29–32.Google Scholar
- 11.London, GM, Marchais, SI, Guerin, AP, Metivier F. 1989. Contributive factors to cardiovascular hypertrophy in renal failure. Am J Hypertension 2:261S–263S.Google Scholar
- 13.Sassolas A, Courboules P, Leitienne P, Quincy C, Galland R, Traeger J. 1987. Lecithin cholesterol acyltransferase (LCAT) and lipid cardiovascular risk factors in hemodialysis patients. Nwephrologie 8:267–272.Google Scholar